These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 17397826)
1. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide. Fowler CJ; Björklund E; Lichtman AH; Naidu PS; Congiu C; Onnis V J Enzyme Inhib Med Chem; 2013 Feb; 28(1):172-82. PubMed ID: 22225576 [TBL] [Abstract][Full Text] [Related]
3. Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode. Karlsson J; Morgillo CM; Deplano A; Smaldone G; Pedone E; Luque FJ; Svensson M; Novellino E; Congiu C; Onnis V; Catalanotti B; Fowler CJ PLoS One; 2015; 10(11):e0142711. PubMed ID: 26565710 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. Vandevoorde S; Fowler CJ Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen. Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors. Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779 [TBL] [Abstract][Full Text] [Related]
7. Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system. Lenman A; Fowler CJ Br J Pharmacol; 2007 Aug; 151(8):1343-51. PubMed ID: 17592505 [TBL] [Abstract][Full Text] [Related]
8. Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen. Holt S; Nilsson J; Omeir R; Tiger G; Fowler CJ Br J Pharmacol; 2001 Jun; 133(4):513-20. PubMed ID: 11399668 [TBL] [Abstract][Full Text] [Related]
9. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen. Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655 [TBL] [Abstract][Full Text] [Related]
10. Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH. Holt S; Fowler CJ Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):237-44. PubMed ID: 12644895 [TBL] [Abstract][Full Text] [Related]
11. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Ho WS; Randall MD Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen. Fowler CJ; Janson U; Johnson RM; Wahlström G; Stenström A; Norström K; Tiger G Arch Biochem Biophys; 1999 Feb; 362(2):191-6. PubMed ID: 9989926 [TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384 [TBL] [Abstract][Full Text] [Related]
15. Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner. Fowler CJ; Holt S; Tiger G J Enzyme Inhib Med Chem; 2003 Feb; 18(1):55-8. PubMed ID: 12751821 [TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle. Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699 [TBL] [Abstract][Full Text] [Related]
17. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957 [TBL] [Abstract][Full Text] [Related]
18. Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro. Vandevoorde S; Jonsson KO; Labar G; Persson E; Lambert DM; Fowler CJ Br J Pharmacol; 2007 Jan; 150(2):186-91. PubMed ID: 17143303 [TBL] [Abstract][Full Text] [Related]
19. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864 [TBL] [Abstract][Full Text] [Related]